Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

2.18
Delayed Data
As of Oct 20
 +0.06 / +2.83%
Today’s Change
1.41
Today|||52-Week Range
4.09
-6.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$341.0M

Company Description

Antares Pharma, Inc. is a pharmaceutical company. The company focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its activities include the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.

Contact Information

Antares Pharma, Inc.
100 Princeton South
Ewing New Jersey 08628
P:(609) 359-3020
Investor Relations:
(609) 359-3016

Employees

Shareholders

Other institutional24.52%
Individual stakeholders21.19%
Mutual fund holders12.54%

Top Executives

Robert F. ApplePresident, Chief Executive Officer & Director
Patrick MadsenSenior Vice President-Operations
Fred M. PowellChief Financial Officer & Senior Vice President
Peter L. SadowskiSenior Vice President-Technology
Jonathan S. JaffeVice President-Clinical & Medical Affairs